Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prescribing oral contraceptives

E Weisberg1

  • 1Family Planning NSW Ltd, Sydney, Australia.

Drugs
|February 1, 1995
PubMed
Summary
This summary is machine-generated.

Combined oral contraceptives are popular, but breakthrough bleeding is a key side effect. Choosing the right pill formulation and patient education are crucial for effective use and managing side effects.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction: AMN107 (nilotinib): a novel and selective inhibitor of BCR-ABL.

British journal of cancer·2019
Same author

The influence of hypoxia on CML trafficking through modulation of CXCR4 and E-cadherin expression.

Leukemia·2012
Same author

Using combination therapy to override stromal-mediated chemoresistance in mutant FLT3-positive AML: synergism between FLT3 inhibitors, dasatinib/multi-targeted inhibitors and JAK inhibitors.

Leukemia·2012
Same author

Inhibition of CXCR4 in CML cells disrupts their interaction with the bone marrow microenvironment and sensitizes them to nilotinib.

Leukemia·2011
Same author

The JAK2V617F oncogene requires expression of inducible phosphofructokinase/fructose-bisphosphatase 3 for cell growth and increased metabolic activity.

Leukemia·2011
Same author

Smac mimetics: implications for enhancement of targeted therapies in leukemia.

Leukemia·2010
Same journal

The Long Road to Long-Acting: What Oral PrEP and CAB-LA Teach Us About Scaling Lenacapavir.

Drugs·2026
Same journal

Botulinum Toxin Type A for Trigeminal and Postherpetic Neuralgia: An Umbrella Review of Systematic Reviews.

Drugs·2026
Same journal

Biologics and Small Molecule Inhibitors: Novel Therapeutic Strategies for Cutaneous Adverse Drug Reactions.

Drugs·2026
Same journal

Use of Sedative-Hypnotic Drugs and the Risk of Developing Alzheimer's Disease: A Systematic Review, Meta-Analysis and Meta-Regression.

Drugs·2026
Same journal

Relacorilant: First Approval.

Drugs·2026
Same journal

Developmental Progress and Future Potential for Inhaled Biologics in the Treatment of Respiratory Diseases.

Drugs·2026
See all related articles

Area of Science:

  • Reproductive Health
  • Pharmacology
  • Contraception

Background:

  • Combined oral contraceptive pills are the most widely used contraceptive method globally.
  • Modern low-dose formulations enhance patient tolerability.
  • Breakthrough bleeding remains the primary adverse event associated with low-dose combined oral contraceptives.

Purpose of the Study:

  • To review the different formulations of combined oral contraceptives.
  • To highlight the importance of individualized formulation selection.
  • To emphasize patient counseling regarding usage and side effects.

Main Methods:

  • Review of available literature on combined oral contraceptive formulations.
  • Analysis of common adverse events, particularly breakthrough bleeding.

Related Experiment Videos

  • Discussion of patient-centered approaches to oral contraceptive selection and management.

    • Main Results:

    • Various formulations exist, including monophasic, biphasic, triphasic, and progestogen-only pills.
    • Breakthrough bleeding is a significant concern with low-dose combined oral contraceptives.
    • Effective patient education on usage, side effects, and missed pill management is vital.

    Conclusions:

    • The selection of combined oral contraceptive formulation should be individualized.
    • Comprehensive patient counseling is essential for effective and safe oral contraceptive use.
    • Addressing patient concerns and providing clear instructions improves adherence and outcomes.